Possible role of plasma Galectin-9 levels as a surrogate marker of viremia in HIV infected patients on antiretroviral therapy in resource-limited settings.

CONCLUSIONS: Plasma Galectin-9 levels could identify viremic individuals with sensitivity and specificity of more than 90%. Thus, they showed a potential to serve as a surrogate marker of viremia in HIV infected patients on ART and would have cost implications on HIV management especially in resource-limited settings. However, the findings need to be confirmed in the patients on ART for different durations of time.
PMID: 32678033 [PubMed - as supplied by publisher]

Source: AIDS Research and Therapy - July 15, 2020 Category: Infectious Diseases Authors: Shete A, Dhayarkar S, Dhamanage A, Kulkarni S, Ghate M, Sangle S, Medhe U, Verma V, Rajan S, Hattori T, Gangakhedkar R Tags: AIDS Res Ther Source Type: research